TEM Tempus AI Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
13:53
Oct 09
Oct 09
r/stocks
AI-first precision medicine tools for healthcare and life sciences
The author lists Tempus as a standout AI-core company that uses artificial intelligence and large-scale data to build precision medicine tools for healthcare and life sciences. He argues ground-up AI companies like Tempus provide huge improvements over legacy competitors that must pivot or fire employees. No specific catalyst, time horizon, or risk is stated.
17:49
Oct 08
Oct 08
Анатолий Радченко | Финансовый кружок
Tempus dip offers asymmetric breakout trade
Tempus fell from about 90 to 67 in three days in a sector-wide genomics sell-off, not on company news. Radchenko likes its volatile run-ups toward the highs. With entry around 67–68 and about $7–10 of risk (he doubts it goes below ~58–60), a breakout could carry it to roughly 100–150.
11:50
Oct 03
Oct 03
Chesley Investment Advisory
NGS demand rising; buy sequencing equipment.
NGS (next-generation sequencing) demand is rising strongly, led by Illumina, Natera, and Tempus. ASPs are increasing, penetration is still low, and fundamentals are good, making it a strong biotech equipment area.
About TEM Investor Commentary
Across the available history and selected sources, Buzzberg tracks TEM (Tempus AI) across 33 sources: 57 bullish vs 0 bearish calls from 48 authors. Historical directional balance: 36% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 160 total trade ideas tracked. Past 7 days, before deduplication: 6 other directions. Latest voices: u/DoU92, Anatoly Radchenko, Shin Woo-young.